{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T02:55:27Z","timestamp":1773802527586,"version":"3.50.1"},"reference-count":42,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2019,1,7]],"date-time":"2019-01-07T00:00:00Z","timestamp":1546819200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0210085","type":"journal-article","created":{"date-parts":[[2019,1,8]],"date-time":"2019-01-08T02:32:29Z","timestamp":1546914749000},"page":"e0210085","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":13,"title":["Associations between urate-lowering therapy and the risk of type 2 diabetes mellitus"],"prefix":"10.1371","volume":"14","author":[{"given":"Hsin-Wen","family":"Chang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ya-Wen","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming-Hung","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-Ching","family":"Lan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8262-0873","authenticated-orcid":true,"given":"Ruey-Yun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2019,1,7]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.diabres.2017.03.024","article-title":"IDF Diabetes Atlas: Global estimates for the prevalence of diabetes for 2015 and 2040","volume":"128","author":"K Ogurtsova","year":"2017","journal-title":"Diabetes Res Clin Pract"},{"issue":"2","key":"ref2","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1097\/BOR.0b013e3283438e13","article-title":"Risk factors for gout and prevention: a systematic review of the literature","volume":"23","author":"JA Singh","year":"2011","journal-title":"Curr Opin Rheumatol"},{"issue":"6","key":"ref3","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.3346\/jkms.2005.20.6.1029","article-title":"The prevalence of metabolic syndrome in patients with gout: a multicenter study","volume":"20","author":"YH Rho","year":"2005","journal-title":"J Korean Med Sci"},{"issue":"8","key":"ref4","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1161\/CIRCULATIONAHA.107.703389","article-title":"Independent impact of gout on mortality and risk for coronary heart disease","volume":"116","author":"HK Choi","year":"2007","journal-title":"Circulation"},{"issue":"6","key":"ref5","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1161\/01.HYP.0000069700.62727.C5","article-title":"Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease?","volume":"41","author":"RJ Johnson","year":"2003","journal-title":"Hypertension"},{"issue":"2","key":"ref6","doi-asserted-by":"crossref","first-page":"361","DOI":"10.2337\/dc07-1276","article-title":"High serum uric acid as a novel risk factor for type 2 diabetes","volume":"31","author":"A Dehghan","year":"2008","journal-title":"Diabetes Care"},{"issue":"10","key":"ref7","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.amjmed.2010.03.027","article-title":"Serum uric acid levels and the risk of type 2 diabetes: a prospective study","volume":"123","author":"V Bhole","year":"2010","journal-title":"Am J Med"},{"issue":"8","key":"ref8","doi-asserted-by":"crossref","first-page":"2720","DOI":"10.2337\/db15-0532","article-title":"Causal or Noncausal Relationship of Uric Acid With Diabetes","volume":"64","author":"RJ Johnson","year":"2015","journal-title":"Diabetes"},{"issue":"8","key":"ref9","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1097\/JIM.0000000000000242","article-title":"Lowering Uric Acid With Allopurinol Improves Insulin Resistance and Systemic Inflammation in Asymptomatic Hyperuricemia","volume":"63","author":"M Takir","year":"2015","journal-title":"J Investig Med"},{"issue":"1","key":"ref10","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1161\/CIRCHEARTFAILURE.109.868604","article-title":"Uric acid-lowering treatment with benzbromarone in patients with heart failure: a double-blind placebo-controlled crossover preliminary study","volume":"3","author":"K Ogino","year":"2010","journal-title":"Circ Heart Fail"},{"issue":"10","key":"ref11","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1093\/rheumatology\/ken305","article-title":"Gout and the risk of type 2 diabetes among men with a high cardiovascular risk profile","volume":"47","author":"HK Choi","year":"2008","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"ref12","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1136\/annrheumdis-2014-205827","article-title":"Independent impact of gout on the risk of diabetes mellitus among women and men: a population-based, BMI-matched cohort study","volume":"75","author":"YH Rho","year":"2016","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"ref13","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1001\/jamainternmed.2015.3536","article-title":"Allopurinol Use and Risk of Fatal Hypersensitivity Reactions: A Nationwide Population-Based Study in Taiwan","volume":"175","author":"CY Yang","year":"2015","journal-title":"JAMA Intern Med"},{"issue":"5","key":"ref14","first-page":"443","article-title":"Clinical practice. Gout","volume":"364","author":"T. Neogi","year":"2011","journal-title":"N Engl J Med"},{"issue":"9711","key":"ref15","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/S0140-6736(09)60883-7","article-title":"Gout","volume":"375","author":"P Richette","year":"2010","journal-title":"Lancet"},{"issue":"5","key":"ref16","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/nrrheum.2014.32","article-title":"Optimizing current treatment of gout","volume":"10","author":"F Rees","year":"2014","journal-title":"Nat Rev Rheumatol"},{"issue":"6887","key":"ref17","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/nature742","article-title":"Molecular identification of a renal urate anion exchanger that regulates blood urate levels","volume":"417","author":"A Enomoto","year":"2002","journal-title":"Nature"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s13075-015-0522-8","article-title":"Epidemiology and management of gout in Taiwan: a nationwide population study","volume":"17","author":"CF Kuo","year":"2015","journal-title":"Arthritis Res Ther"},{"issue":"3","key":"ref19","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0168-8510(96)00877-9","article-title":"Taiwan's 1995 health care reform","volume":"39","author":"TL Chiang","year":"1997","journal-title":"Health Policy"},{"issue":"11","key":"ref20","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1097\/01.mlr.0000182534.19832.83","article-title":"Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data","volume":"43","author":"H Quan","year":"2005","journal-title":"Med Care"},{"issue":"11","key":"ref21","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1038\/nrrheum.2014.124","article-title":"Improving cardiovascular and renal outcomes in gout: what should we target?","volume":"10","author":"P Richette","year":"2014","journal-title":"Nat Rev Rheumatol"},{"issue":"4","key":"ref22","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1159\/000464260","article-title":"Elevated Serum Uric Acid Level Predicts Rapid Decline in Kidney Function","volume":"45","author":"M Kuwabara","year":"2017","journal-title":"Am J Nephrol"},{"issue":"8","key":"ref23","doi-asserted-by":"crossref","first-page":"3028","DOI":"10.2337\/db14-0742","article-title":"A Mendelian Randomization Study of Circulating Uric Acid and Type 2 Diabetes","volume":"64","author":"I Sluijs","year":"2015","journal-title":"Diabetes"},{"issue":"11","key":"ref24","doi-asserted-by":"crossref","first-page":"e50046","DOI":"10.1371\/journal.pone.0050046","article-title":"Reduced glomerular function and prevalence of gout: NHANES 2009\u201310","volume":"7","author":"E. Krishnan","year":"2012","journal-title":"PLoS One"},{"issue":"6","key":"ref25","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1161\/HYPERTENSIONAHA.116.08998","article-title":"Asymptomatic Hyperuricemia Without Comorbidities Predicts Cardiometabolic Diseases: Five-Year Japanese Cohort Study","volume":"69","author":"M Kuwabara","year":"2017","journal-title":"Hypertension"},{"issue":"3","key":"ref26","doi-asserted-by":"crossref","first-page":"380","DOI":"10.3899\/jrheum.160792","article-title":"Sex-specific Relationship of Serum Uric Acid with All-cause Mortality in Adults with Normal Kidney Function: An Observational Study","volume":"44","author":"E Kang","year":"2017","journal-title":"J Rheumatol"},{"issue":"9654","key":"ref27","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1016\/S0140-6736(08)61343-4","article-title":"Association of three genetic loci with uric acid concentration and risk of gout: a genome-wide association study","volume":"372","author":"A Dehghan","year":"2008","journal-title":"Lancet"},{"issue":"4","key":"ref28","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.jacc.2015.10.086","article-title":"Causal Assessment of Serum Urate Levels in Cardiometabolic Diseases Through a Mendelian Randomization Study","volume":"67","author":"T Keenan","year":"2016","journal-title":"J Am Coll Cardiol"},{"issue":"10","key":"ref29","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1007\/s00125-011-2235-0","article-title":"No evidence for a causal link between uric acid and type 2 diabetes: a Mendelian randomisation approach","volume":"54","author":"R Pfister","year":"2011","journal-title":"Diabetologia"},{"issue":"9","key":"ref30","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1136\/ard.50.9.631","article-title":"Effects of pyrazinamide, probenecid, and benzbromarone on renal excretion of oxypurinol","volume":"50","author":"T Yamamoto","year":"1991","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"ref31","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1002\/art.10511","article-title":"Effect of urate-lowering therapy on the velocity of size reduction of tophi in chronic gout","volume":"47","author":"F Perez-Ruiz","year":"2002","journal-title":"Arthritis Rheum"},{"issue":"2","key":"ref32","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1093\/aje\/kws002","article-title":"Hyperuricemia in young adults and risk of insulin resistance, prediabetes, and diabetes: a 15-year follow-up study","volume":"176","author":"E Krishnan","year":"2012","journal-title":"Am J Epidemiol"},{"issue":"10","key":"ref33","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1002\/acr.21772","article-title":"2012 American College of Rheumatology guidelines for management of gout. Part 1: systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia","volume":"64","author":"D Khanna","year":"2012","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"4","key":"ref34","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1136\/annrheumdis-2013-204463","article-title":"Rising burden of gout in the UK but continuing suboptimal management: a nationwide population study","volume":"74","author":"CF Kuo","year":"2015","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"ref35","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1002\/acr.22336","article-title":"Medication adherence in gout: a systematic review","volume":"66","author":"MA De Vera","year":"2014","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"ref36","article-title":"Gout","author":"N Dalbeth","year":"2016","journal-title":"Lancet"},{"issue":"1","key":"ref37","first-page":"104","article-title":"Frequency and predictors of inappropriate management of recurrent gout attacks in a longitudinal study","volume":"33","author":"T Neogi","year":"2006","journal-title":"J Rheumatol"},{"issue":"9","key":"ref38","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1038\/nrrheum.2015.94","article-title":"Gout: Why compare the effectiveness of suboptimal gout management?","volume":"11","author":"N Dalbeth","year":"2015","journal-title":"Nat Rev Rheumatol"},{"issue":"6","key":"ref39","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1136\/annrheumdis-2012-201676","article-title":"Patients with gout adhere to curative treatment if informed appropriately: proof-of-concept observational study","volume":"72","author":"F Rees","year":"2013","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"ref40","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1002\/art.30119","article-title":"Using allopurinol above the dose based on creatinine clearance is effective and safe in patients with chronic gout, including those with renal impairment","volume":"63","author":"LK Stamp","year":"2011","journal-title":"Arthritis Rheum"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1186\/s12891-015-0614-2","article-title":"Validity of gout diagnosis in Swedish primary and secondary care\u2014a validation study","volume":"16","author":"M Dehlin","year":"2015","journal-title":"BMC Musculoskelet Disord"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"b5087","DOI":"10.1136\/bmj.b5087","article-title":"Problem of immortal time bias in cohort studies: example using statins for preventing progression of diabetes","volume":"340","author":"LE Levesque","year":"2010","journal-title":"BMJ"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0210085","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,9]],"date-time":"2022-09-09T21:20:05Z","timestamp":1662758405000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0210085"}},"subtitle":[],"editor":[{"given":"Tatsuo","family":"Shimosawa","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2019,1,7]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,1,7]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0210085","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,7]]}}}